Core Viewpoint - Cambrian (688256.SH) is facing a lawsuit from former CTO Liang Jun, who claims a labor relationship existed from October 18, 2017, to February 10, 2022, and is seeking compensation for stock incentive losses amounting to 4.287 billion yuan [1] Summary by Relevant Sections - **Lawsuit Details** - The plaintiff is requesting confirmation of a labor relationship during the specified period [1] - The lawsuit includes a claim for compensation of 4.287 billion yuan due to stock incentive losses, based on an indirect holding of 11.5232 million shares at a maximum price of 372 yuan per share [1] - The plaintiff also seeks to have the defendant bear the litigation costs [1] - **Background Information** - The defendant issued a "Letter of Intent" to the plaintiff on July 31, 2017, with an agreement for the plaintiff to join the company by November 30, 2017, including salary and stock incentive terms [1] - The plaintiff served as the Chief Technology Officer and received stock incentives after joining [1] - Cambrian successfully went public on the Sci-Tech Innovation Board on July 20, 2020, with the plaintiff holding 11.5232 million shares indirectly [1] - **Claims and Allegations** - The plaintiff alleges that Cambrian failed to fulfill the terms of the "Letter of Intent" and did not provide the agreed working conditions, leading to the forced termination of the labor contract on February 10, 2022 [1] - The plaintiff's shares were set to be unlocked on January 2, 2024, and claims that the company did not cooperate with a request to reduce holdings [1]

智通财经APP讯，寒武纪(688256.SH)发布公告，近日，公司收到北京市海淀区人民法院送达的关于原 告梁军起诉公司的《起诉状》。原告起诉要求：(1)请求确认原告与被告自2017年10月18日至2022年2月 10日期间存在劳动关系;(2)请求被告赔偿股权激励损失42.87亿元(原告间接持有寒武纪股票1152.32万 股，单价根据2024年1月2日至起诉时寒武纪股票最高价372元(2024年10月10日)确定);(3)案件诉讼费用由 被告承担。 2017年7月31日，被告向原告发出《入职意向书》，双方协商原告于2017年11月30日之前入职被告处， 并约定了原告年薪、股权授予等内容。原告自入职被告后担任首席技术官岗位，并获得被告股权激励。 被告于2020年7月20日在科创板成功上市，原告间接持有被告股票1152.32万股。原告称，2022年2月10 日，被告未履行《入职意向书》的约定，且未按照劳动合同约定提供劳动条件，原告被迫解除劳动合 同;2024年1月2日，其间接持有的寒武纪股票解禁。原告曾提出减持申请，被告不配合减持。 ...

中信证券股份有限公司关于中科寒武纪科技股份有限公司 增加募集资金投资项目实施主体及实施地点 并使用募集资金向全资子公司增资的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为中科寒武 纪科技股份有限公司（以下简称"寒武纪"、"公司"）2025 年度向特定对象发行 A 股股票项目的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法律法规和规范性文件的要求，对寒武纪使用募集资金 向全资子公司增资事项进行了审慎核查，具体情况如下： 一、募集资金及募投项目的基本情况 经上海证券交易所科创板上市审核中心审核通过，并根据中国证券监督管理 委员会出具的《关于同意中科寒武纪科技股份有限公司向特定对象发行股票注册 的批复》（证监许可〔2025〕1969 号），公司 2025 年度向特定对象发行 A 股股票 （以下简称"本次发行"）3,334,946 股，每股发行价格为人民币 1,195.02 元，募 集资金总额为人民币 3,985,327,168.92 元，扣除各项发行费用（不含税）人民币 32,1 ...

使用部分暂时闲置募集资金进行现金管理的核查意见 中信证券股份有限公司关于中科寒武纪科技股份有限公司 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为中科寒武 纪科技股份有限公司（以下简称"寒武纪"、"公司"）2025 年度向特定对象发行 A 股股票项目的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法律法规和规范性文件的要求，对寒武纪使用募集资金 向全资子公司增资事项进行了审慎核查，具体情况如下： 一、募集资金基本情况 经上海证券交易所科创板上市审核中心审核通过，并根据中国证券监督管理 委员会出具的《关于同意中科寒武纪科技股份有限公司向特定对象发行股票注册 的批复》（证监许可〔2025〕1969 号），公司 2025 年度向特定对象发行 A 股股票 （以下简称"本次发行"）3,334,946 股，每股发行价格为人民币 1,195.02 元，募 集资金总额为人民币 3,985,327,168.92 元，扣除各项发行费用（不含税）人民币 32,171,304.93 元后，实际募集资金净额为人 ...

一、募集资金基本情况 经上海证券交易所科创板上市审核中心审核通过，并根据中国证券监督管理 委员会出具的《关于同意中科寒武纪科技股份有限公司向特定对象发行股票注册 的批复》（证监许可〔2025〕1969 号），公司 2025 年度向特定对象发行 A 股股票 （以下简称"本次发行"）3,334,946 股，每股发行价格为人民币 1,195.02 元，募 集资金总额为人民币 3,985,327,168.92 元，扣除各项发行费用（不含税）人民币 32,171,304.93 元后，实际募集资金净额为人民币 3,953,155,863.99 元。上述募集 资金已于 2025 年 9 月 26 日到账，到位情况已经天健会计师事务所（特殊普通合 伙）审验并于 2025 年 9 月 29 日出具《验资报告》（天健验〔2025〕294 号）。 根据相关法律法规的要求，公司对本次发行的募集资金进行专户存储，并已 与保荐机构中信证券股份有限公司及募集资金专户存储的商业银行签订了《募集 资金专户存储三方监管协议》。 二、募集资金投资项目情况 中信证券股份有限公司关于中科寒武纪科技股份有限公司 使用自有资金支付募投项目所需资金 并以募 ...

使用部分闲置募集资金暂时补充流动资金的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为中科寒武 纪科技股份有限公司（以下简称"寒武纪"、"公司"）2025 年度向特定对象发行 A 股股票项目的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法律法规和规范性文件的要求，对寒武纪使用募集资金 向全资子公司增资事项进行了审慎核查，具体情况如下： | 发行名称 | 2025 年度向特定对象发行 | A 股股票 | | --- | --- | --- | | 募集资金总额 | 398,532.72 | 万元 | | 募集资金净额 | 395,315.59 | 万元 | | 募集资金到账时间 | 2025 年 9 | 月 26 日 | | 前次用于暂时补充流动资金的募集资金归还 | 不适用 | | | 日期及金额 | | | 中信证券股份有限公司关于中科寒武纪科技股份有限公司 一、募集资金基本情况 经上海证券交易所科创板上市审核中心审核通过，并根据中国证券监督管理 委员会出具的《关于同意中科 ...

支付发行费用的自筹资金的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为中科寒武 纪科技股份有限公司（以下简称"寒武纪"、"公司"）2025 年度向特定对象发行 A 股股票项目的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法律法规和规范性文件的要求，对寒武纪使用募集资金 向全资子公司增资事项进行了审慎核查，具体情况如下： 中信证券股份有限公司关于中科寒武纪科技股份有限公司 使用向特定对象发行 A 股股票募集资金置换预先投入募投项目及已 一、募集资金基本情况 经上海证券交易所科创板上市审核中心审核通过，并根据中国证券监督管理 委员会出具的《关于同意中科寒武纪科技股份有限公司向特定对象发行股票注册 的批复》（证监许可〔2025〕1969 号），公司 2025 年度向特定对象发行 A 股股票 （以下简称"本次发行"）3,334,946 股，每股发行价格为人民币 1,195.02 元，募 集资金总额为人民币 3,985,327,168.92 元，扣除各项发行费用（不含税）人民币 32 ...

Core Viewpoint - Cambricon has disclosed a labor dispute lawsuit involving a former executive, which is currently accepted by the Haidian District People's Court in Beijing and has not yet been heard [1][3]. Group 1: Lawsuit Details - The plaintiff, Liang Jun, a former vice president of the company, left in early 2022 and is seeking three main requests: confirmation of an employment relationship from October 18, 2017, to February 10, 2022; compensation for stock incentive losses amounting to RMB 4,286,624,448, based on 11,523,184 shares held indirectly, calculated at the highest stock price of RMB 372 as of October 10, 2024; and the company to bear the litigation costs [3]. - Cambricon responded that Liang did not directly hold shares before leaving and that his stock incentive rights were subject to a buyback clause in the "Shareholding Plan B," which he refused to cooperate with after leaving during the restriction period [3][4]. Group 2: Previous Legal Actions - Liang has previously filed two lawsuits regarding the partnership agreement related to the shareholding platform, both of which were dismissed by the court or arbitration institutions, with the rulings now effective [4]. - The arbitration ruling confirmed that Liang was aware of and agreed to the terms of the "Shareholding Plan" when signing it, thus he is bound by its provisions [4]. Group 3: Company Response and Impact - Cambricon has engaged a legal team to analyze Liang's claims comprehensively and will actively respond to the lawsuit to protect the company's and investors' legal rights [4]. - The company believes that this lawsuit will not affect its daily research and operations, and since the case has not yet been heard, it expects no impact on current profits, with future profit effects depending on the final court ruling [4].

Core Viewpoint - Cambrian (688256) announced on October 31 the establishment of new wholly-owned subsidiaries in Shanghai, Shenzhen, Anhui, and Xi'an to implement fundraising investment projects focused on large model chip and software platforms [1] Group 1: Fundraising and Investment - The company plans to use 1 billion yuan to increase capital in Shanghai Cambrian [1] - An additional 80 million yuan will be allocated for capital increase in Anhui Cambrian [1] - Another 80 million yuan will be used for capital increase in Xi'an Cambrian [1] Group 2: Fund Management - The company will establish dedicated fundraising accounts in Shanghai Cambrian, Shenzhen branch, Anhui Cambrian, and Xi'an Cambrian [1] - The management is authorized to sign and handle the regulatory agreements for opening these fundraising accounts [1]

Core Viewpoint - The company announced the approval of a proposal to temporarily use idle raised funds to supplement working capital, amounting to no more than RMB 1 billion [1] Group 1 - The second meeting of the company's second board and the twenty-seventh meeting of the second supervisory board will be held on October 31, 2025 [1] - The approved proposal allows the company and Shanghai Cambrian to use idle raised funds for a period of 12 months from the date of board approval [1] - The purpose of the fund usage is to temporarily supplement working capital [1]